TI
RLYB icon

Trexquant Investment’s Rallybio RLYB Stock Holding History

Trexquant Investment’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,975
Closed -$110K – 1814
2022
Q1 		$110K Buy
+1,975
New +$163K 0.01% 1270

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Trexquant Investment's RLYB Position: Q2 2022 in Review

Trexquant Investment sold out of Rallybio (RLYB) in Q2 2022, closing a stake of 1,975 shares — an estimated $110K sold.

Trexquant Investment first reported a position in RLYB in Q1 2022 and held it in 1 quarter. The position peaked at $110K in Q1 2022. 47 funds tracked by Wall St. Rank hold RLYB as of Q2 2022.

  • Trexquant Investment reported no remaining Rallybio position as of Q2 2022 after selling out during the quarter.
  • Trexquant Investment sold 1,975 Rallybio shares in Q2 2022, an estimated $110K.
  • Trexquant Investment first reported a position in Rallybio in Q1 2022 and held it in 1 quarter.
  • Trexquant Investment's Rallybio position peaked at $110K in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Rallybio as of Q2 2022.

Based on Trexquant Investment's 13F filing for Q2 2022, filed 11 Aug 2022.